Loss of 18q and homozygosity for the DCC locus: Possible markers for clinically aggressive squamous cell carcinoma

Anticancer Research

Volumn 16, Issue 4 C, 1996, Pages 2365-2372

  Kelker, Wolfgang ^a,d   Van Dyke, Daniel L ^b   Worsham, Maria J ^b   Christopherson, Patricia L ^b   James, C David ^c   Conlon, Margaret R ^a   Carey, Thomas E ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c EMORY UNIVERSITY   (United States)

^d Box 0506 ^*  (Germany)

Author keywords

Chromosomes; DCC locus; Homozygosity; Loss; Squamous cell carcinoma

Indexed keywords

MARKER;

ALLELE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 18Q; CHROMOSOME LOSS; CONTROLLED STUDY; GENE LOCUS; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPING; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TISSUE CULTURE; TUMOR SUPPRESSOR GENE; ZYGOSITY;

CARCINOMA, SQUAMOUS CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; GENES, DCC; HUMANS;

EID: 0029789485     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Carey TE, Van Dyke DL, Worsham MJ, Babu VR, Schwartz DR, Hsu S, Baker SR: Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B. Cancer Res 49: 6098-6107, 1989.
2. Heo DS, Snyderman C, Gollin SM, Pan S, Walker E, Deka R, Barnes EL, Johnson JT, Herberman RB, Whiteside TL: Biology, cytogenetics and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma cell lines. Cancer Res 49: 5167-5175, 1989.
3. Whang-Peng J, Banks-Schelegel SP, Lee EC: Cytogenetic studies of esophageal carcinoma cell lines. Cancer Genet Cytogenet 45: 101-120, 1990.
4. Worsham MJ, Van Dyke DL, Grenman SE, Grenman R, Hopkins MA, Roberts JA, Gasser KM, Schwartz DR, Carey TE: Consistent chromosome abnormalities in squamous cell carcinoma of the vulva. Genes Chrom Cancer 3: 420-432, 1991.
5. Bradford CR, Kimmel KA, Van Dyke DL, Worsham MJ, Tilley BJ, Burk D, del Rosario F, Lutz S, Tooley R, Hayshida DJS, Carey TE: 11p deletions and breakpoints in squamous cell carcinoma: Association with altered reactivity with the UM-E7 antibody. Genes Chrom Cancer 3: 272-282, 1991.
6. Jin Y, Higashi K, Mandahl N, Heim S, Wennerberg J, Dictor M, Mitelman: Frequent rearrangement of chromosomal bands 1p22 and 11q13 in squamous cell carcinomas of the head and neck. Genes Chrom Cancer 2: 198-204, 1991.
7. Cowan JM, Beckett MA, Ahmed-Swan S, Weichselbaum RR: Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. J Natl Cancer Inst 84: 793-797, 1992.
8. Carey TE, Worsham MJ, Van Dyke DL: Chromosomal biomarkers in the clonal evolution of head and neck squamous neoplasia. J Cell Biochem Suppl 17F: 213-222, 1993.
9. Carey TE, Van Dyke DL, Worsham MJ: Nonrandom chromosome aberrations and clonal populations in head and neck cancer. Anticancer Res 13: 2561-2568, 1993.
10. Worsham MJ, Benninger MJ, Zarbo RJ, Carey TE, Van Dyke DL: Deletion 9p22-pter and loss of Y as primary chromosome abnormalities in a squamous cell carcinoma of the vocal cord. Genes Chrom Cancer 6: 58-60, 1993.
11. Worsham MJ, Carey TE, Benninger MS, Gasser KM, Kelker W, Zarbo RJ, Van Dyke DL: Clonal cytogenetic evolution in a squamous cell carcinoma of the skin from a xeroderma pigmentosum patient. HFH-SCC-XP1. Genes Chrom Cancer 7: 158-164, 1993.
12. Van Dyke DL, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T, Tilley BC, Carey TE: Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chrom Cancer 9: 192-206, 1994.
13. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benniger MS, Van Dyke DL: Common clonal origin of synchronous primary head and neck squamous cell carcinomas: Analysis by tumor karyotypes and fluorescence in situ hybridization. Human Path 26: 251-261, 1995.
14. Jin Y, Mertens F, Mandahl N, Heim S, Olegard C, Wennerherg J, Biorkland A, Mitelman F: Chromosome abnormalities in eighty-three head and neck squamous cell carcinomas: Influence of culture conditions on karyotypic pattern. Cancer Res 53: 2140-2146, 1993.
15. Fearon ER, Vogelstein B: A genetic model tor colorectal tumorigenesis. Cell 61: 759-767, 1993.
16. Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A, Peters G: D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6: 439-444, 1991.
17. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman HM, Kronenberg HM, Arnold A: A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350: 512-515, 1991.
18. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D: Allelotype of squamous cell carcinoma. Cancer Res 54: 1152-1155, 1994.
19. Ah-See KW, Cooke TG, Pickford IR, Soutar D, Balmain A: An Allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 54: 1617-1621, 1994.
20. Li X, Lee NK, Ye Y-W, Waber PG, Schweitzer C, Cheng, Q-C Nisen, PD: Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst 86: 1524-1529, 1994.
21. van der Riet P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, Sidransky D: Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 54: 1156-1158, 1994.
22. Loughran O, Edington KG, Berry U, Clark LJ, Parkinson EK: Loss of heterozygosity of chromosome 9p21 is associated with immortal phenotype of neoplastic human head and neck keratinocytes. Cancer Res 54: 5045-504, 1994.
23. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y: Frequent somatic mutations of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396-3397, 1994.
24. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D: Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265: 415-416, 1994.
25. Kelker W, Van Dyke DL, Worsham MJ, Benninger MJ, James CD, Carey TE: Molecular zygosity analysis of the DCC gene at 18q21.3 confirms high frequency cytogenetic loss in squamous cell carcinoma. Proc Am Assoc Cancer Res 33: 264, 1992.
26. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
27. Fearon E, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B: Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247: 49-56, 1990.
28. Gibas LM, Gibas Z, Sandberg AA: Technical aspects of cytogenetic analysis of human solid tumors. Karyogram 10: 25-27, 1984.
29. Jen J, Kim H, Piantadosi S, Liu Z-F, Levitt RC, Sistonen P, Kinzler KW, Vogelstein B, Hamilton SR: Allelic loss of chromosome 18q and prognosis in colorectal cancer. New Engl J Med 331: 213-221, 1994.
30. Reale M, Hu G, Zafar AI, Getzenberg RH, Levine SM, Fearon ER: Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res 54: 4493-4501, 1994.
31. Hohne MW, Halatsch M-E, Kahllll GF, Weinel RJ: Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res 52: 2612-2619, 1992.
32. Gao X, Honn KV, Grignon D, Sakr W, Chen YO: Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res 53: 2723-2727, 1993.
33. Brewster SF, Gingell JC, Browne S, Brown KW: Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional carcinoma of the bladder. Br. J Cancer 70: 697-700, 1994.
34. Miyake S, Nagai K, Yoshino K, Oto M, Endo M, Yuasa Y: Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. Cancer Res 54: 3007-3010, 1994.
35. Klingelhutz AJ, Smith PP, Garett LR, McDougall JK: Alteration of the DCC tumor-suppressor gene in tumorigenic HPV-18 immortalized human keratinocytes transformed by nitrosomethylurea. Oncogene 8: 95-99, 1993
36. Steenbergen RDM, Hermsen MAJA, Walbloomers JMM, Joene H, Arwert F, Meijer CJLM, Snijders PJF: Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in oral carcinoma and its derivative cell line. Cancer Res 55: 5465-5471, 1995.
37. Klingelhutz AJ, Hedrick L, Cho KR, McDougall JK: The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 10: 1581-1586, 1995.
38. Tanaka K, Oshimura M, Kikuchi R, Seki M, Hayashi T, Miyaki M: Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature 349: 340-342, 1991.
39. Rowley H, Jones AS, Field JK: Chromosome 18: a possible site for a tumour suppressor gene deletion in squamous cell carcinoma of the head and neck. Clin Otolaryngol 20: 266-271, 1995.